Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:280-281
doi: 10.1161/01.CIR.0000018080.37316.D6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshima, Y.
Right arrow Articles by Kawase, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshima, Y.
Right arrow Articles by Kawase, I.
Related Collections
Right arrow Lipids
Right arrow Myocardial cardiomyopathy disease

(Circulation. 2002;106:280.)
© 2002 American Heart Association, Inc.


Images in Cardiovascular Medicine

Specific Cardiomyopathy Caused by Multisystemic Lipid Storage in Jordan’s Anomaly

Yuichi Oshima, MD; Hisao Hirota, MD; Hiroyuki Nagai, MD; Masahiro Izumi, MD; Yoshikazu Nakaoka, MD; Tomoaki Osugi, MD; Yasushi Fujio, MD; Hitone Tateyama, MD; Masanori Kikui, MD; Keiko Yamauchi-Takihara, MD; Ichiro Kawase, MD

From the Department of Molecular Medicine (Y.O., H.N., M.I., Y.N., T.O., Y.F., K.Y.-T., I.K.), Osaka University Graduate School of Medicine; Internal Medicine (H.T.), Tominaga Hospital; and Department of Pathology (M.K.), Osaka Prefectural Habikino Hospital, Osaka, Japan.

Correspondence to Hisao Hirota, MD, Department of Molecular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871 Japan. E-mail hirota@imed3.med.osaka-u.ac.jp


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A 28-year-old Japanese man was admitted in 1996 with persistently high levels of serum creatine kinase (CK), glutamic oxaloacetic transaminase (GOT), and glutamic pyruvic transaminase (GPT). Physical examination revealed no skin disorder, but showed neurosensory hearing loss and early fatigability. The CK level was 1298 U/L (normal <90 U/L), the GOT level 73 U/L (normal <30 U/L), and the GPT level 79 U/L (normal <30 U/L) on admission. The patient’s serum carnitine level was 1.57 mg/dL (normal 1.22 to 1.86 mg/dL). Typical findings of Jordan’s anomaly were noted on his peripheral blood smear (Figure 1) and several vacuoles were seen in the leukocytes. Sections of a muscle biopsy revealed striking vacuolation, predominantly of the type-1 fibers. The oil-red O preparation disclosed abnormal lipid storage myopathy that was most visible in type-1 fibers and less conspicuous in type-2 fibers. The glycogen content of the muscle fibers was not increased. The patient was diagnosed with systemic lipid storage with Jordan’s anomaly.


Figure Removed (Available Only in the Full Text)
View larger version (114K):
[in this window]
[in a new window]
 
Figure 1. Peripheral blood smear. May-Grunwald-Giemsa stain; original magnification x600. Many vacuoles are seen in the cytoplasm of granulocytes (Jordan’s anomaly).

In 2001, he began complaining of mild exertional dyspnea. Dilated cardiomyopathy was diagnosed by echocardiography and cardiac catheterization. Left ventriculography showed left ventricular (LV) dilatation with an end-diastolic volume (EDV) of 248 mL, diffuse hypokinesis of the LV wall, and decreased LV ejection fraction (EF) at 45%. In the biopsied LV myocardium specimen, vacuoles were seen in the cytoplasm of the myocardial cells. Electron microscopic examination revealed . . . [Full Text of this Article]